Baxter International (HAM:BTL) Inventories, Finished Goods: €1,176 Mil (As of Mar. 2026)


HAM:BTL Baxter International Inc HAM:BTL
59 GF Score
Price €19.43
GF Value €29.76
! 7 Warning Signs
View Full Analysis

What is Baxter International Inventories, Finished Goods?

Baxter International HAM:BTL +1.20% 59 Inventories, Finished Goods is €1,176 Mil as of Mar. 2026. GuruFocus rates HAM:BTL with a GF Score™ of 59/100 and a GF Value™ of €29.76. The stock has 7 warning signs investors should review.

Baxter International's quarterly finished goods declined from Sep. 2025 (€1,343 Mil) to Dec. 2025 (€1,133 Mil) but then increased from Dec. 2025 (€1,133 Mil) to Mar. 2026 (€1,176 Mil).

Baxter International's annual finished goods increased from Dec. 2023 (€1,058 Mil) to Dec. 2024 (€1,213 Mil) but then declined from Dec. 2024 (€1,213 Mil) to Dec. 2025 (€1,133 Mil).

Baxter International Inventories, Finished Goods Historical Data

* Premium members only.

The historical data trend for Baxter International's Inventories, Finished Goods can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baxter International Inventories, Finished Goods Chart

Baxter International Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Finished Goods
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,382.37 1,592.53 1,058.22 1,212.85 1,133.26

Baxter International Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Inventories, Finished Goods Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1,211.75 1,295.30 1,342.75 1,133.26 1,175.54
HAM:BTL
59GF Score
Baxter International Inc HAM:BTL
Inventories, Finished Goods is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baxter International Inventories, Finished Goods Calculation

The products in a manufacturer's inventory that are completed and are waiting to be sold.

What does a Inventories, Finished Goods of €1,176 Mil mean?
Baxter International (HAM:BTL) has a Inventories, Finished Goods of €1,176 Mil as of Mar. 2026. Finished goods are inventory items that are complete and ready to be sold. View historical data on Baxter International and its competitors.
Is Baxter International's Inventories, Finished Goods too high?
Baxter International's current Inventories, Finished Goods is €1,176 Mil. Overall, Baxter International has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Baxter International's Inventories, Finished Goods compare to ALGN and SOLV?
Baxter International's Inventories, Finished Goods of €1,176 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Finished Goods for a Medical Devices & Instruments company?
A good Inventories, Finished Goods depends on the Medical Devices & Instruments industry context. However, Inventories, Finished Goods should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Finished Goods mean?
A high Inventories, Finished Goods can signal that a stock is expensive relative to its fundamentals. Finished goods are inventory items that are complete and ready to be sold. View historical data on Baxter International and its competitors. Baxter International's current Inventories, Finished Goods is €1,176 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baxter International stock overvalued right now?
Baxter International (HAM:BTL) has a current Inventories, Finished Goods of €1,176 Mil. The stock's GF Value™ is €29.76, compared to a current price of €19.43 — trading 34.7% below its estimated fair value. The current Inventories, Finished Goods is €1,176 Mil. Baxter International's overall GF Score™ is 59/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Finished Goods calculated?
Inventories, Finished Goods is calculated from a company's financial statements. For Baxter International (HAM:BTL), the current Inventories, Finished Goods is €1,176 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baxter International (HAM:BTL) Overvalued in 2026?

Based on GuruFocus' analysis, Baxter International stock appears to be undervalued. The current stock price of €19.43 is trading 34.7% below its estimated GF Value™ of €29.76.

Key valuation signals for HAM:BTL:

  • Inventories, Finished Goods: €1,176 Mil
  • GF Value™: €29.76 vs. price of €19.43 (34.7% below fair value)
  • GF Score™: 59/100 with 7 warning signs

No single metric tells the full story. See the HAM:BTL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Baxter International Business Description

Address One Baxter Parkway, Deerfield, IL, USA, 60015
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.
59GF Score

Get the complete analysis for HAM:BTL

Inventories, Finished Goods is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€19.43
Price
€29.76
GF Value